Uscom Limited released details of a study confirming the high accuracy of the Uscom BP+ central blood pressure monitor for detection of the dangerous cardiac rhythm abnormality Atrial Fibrillation (AF) in a primary care setting. This results confirms that BP+ suprasystolic oscillometry is 94% effective for detection of AF in home care environments and may be used as a screening investigation. AF is a common cardiac dysrhythmia occurring in approximately 40m adults worldwide. However AF is associated with significant mortality and morbidity from stroke and heart failure and is often undiagnossed. The presence of AF may warrant the use of prophylactic anticoagulation, which is also associated with additional complications, making the accurate and cost effective detection of AF an important health screening procedure. This study compared Uscom BP+ suprasystolic oscillometric detection of AF with a 12 lead ECG interpreted by a senior cardiology consultant and found an accuracy of 90% for BP+ measures with an overall effectiveness of 94%. Concurrent comparison of a hand held phone with a dual lead ECG attached for detection of AF demonstrated an accuracy of 73%. The Uscom BP+ examination can be performed in approximately 60 seconds by a technician while the 12 lead ECG takes in the order of 15-30 minutes and requires a consultant cardiologist for interpretation. The BP+ suprasystolic monitor is a specialised technology for diagnosis and therapeutic guidance in hypertension and vascular health. The accurate detection of AF as part of the current BP examination using the BP+ suprasystolic oscillometer expands the utility and application of the technology, and simplifies the primary care assessment of cardiovascular risk. The BP+ technology is simple to operate and provides rapid and accurate results, from 58 measures of blood pressure and cardiovascular performance, compared to the 6 presented in current simple BP monitors.